Apellis Pharmaceuticals (APLS) Stock Price & Financial Analysis
Apellis Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Apellis Pharmaceuticals
What is the current stock price for APLS?
As of the latest trading session, APLS stock trades at $40.41. The 52-week range is $16.10–$40.45, with a day range of $40.35–$40.48.
What is the P/E ratio for APLS?
Apellis Pharmaceuticals's trailing P/E ratio is 227.4, meaning investors pay $227.4 for every $1 of annual earnings. Apellis Pharmaceuticals operates in the Healthcare sector.
Does APLS pay dividends?
Apellis Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for APLS?
Based on 24 analysts, the consensus for APLS is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of APLS?
Apellis Pharmaceuticals's market capitalization is $5.09B, classifying it as a mid-cap company. Apellis Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.